Liquidia Corporation (LQDA) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Biotechnology उद्योग. कंपनी का मुख्यालय है Morrisville, NC, United States. वर्तमान CEO हैं Roger A. Jeffs.
LQDA के पास है IPO तिथि 2018-07-26, 170 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Capital Marke, बाजार पूंजीकरण $3.41B.
Liquidia Corporation is a biopharmaceutical company founded in 2004 and headquartered in Morrisville, North Carolina, focused on developing and commercializing innovative treatments for unmet patient needs in the United States. The company's lead product candidate, YUTREPIA, is an inhaled dry powder formulation of treprostinil designed to treat pulmonary arterial hypertension. In addition to its proprietary pipeline, Liquidia manufactures and distributes generic treprostinil injection throughout the U.S. market, combining both innovative drug development and generic pharmaceutical distribution capabilities.
